Prospective study of ampicillin rash. Report of a collaborative study group

Area of Science:

• Pharmacology
• Clinical Medicine
• Infectious Diseases

Background:

• Ampicillin is a widely used penicillin antibiotic.
• Drug-induced rashes are a common concern in clinical practice.
• Differentiating true allergic reactions from other adverse events is crucial for patient management.

Purpose of the Study:

• To investigate the incidence and characteristics of rashes associated with ampicillin treatment.
• To determine if ampicillin-induced maculopapular rashes contraindicate future penicillin use.

Main Methods:

• A multicentre prospective study involving 933 patients treated with ampicillin.
• Data collection on rash incidence, patient demographics, and co-existing conditions (e.g., viral infections).
• Clinical assessment of rash type and association with true penicillin allergy features.

Main Results:

• A 7.3% incidence of rash was observed in patients receiving ampicillin.
• Rashes were more frequent in women and patients with viral infections.
• The majority of observed rashes were maculopapular and lacked indicators of true penicillin allergy.

Conclusions:

• Maculopapular rash during or after ampicillin treatment is not necessarily a sign of true penicillin allergy.
• This type of rash should not automatically preclude future treatment with penicillin-class antibiotics.
• Careful clinical evaluation is needed to distinguish ampicillin rashes from genuine allergic reactions.